A detailed history of Coldstream Capital Management Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Coldstream Capital Management Inc holds 22,364 shares of NVO stock, worth $1.98 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
22,364
Previous 20,533 8.92%
Holding current value
$1.98 Million
Previous $2.93 Million 9.15%
% of portfolio
0.06%
Previous 0.07%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$119.07 - $145.42 $218,017 - $266,264
1,831 Added 8.92%
22,364 $2.66 Million
Q2 2024

Aug 07, 2024

SELL
$122.71 - $146.91 $35,217 - $42,163
-287 Reduced 1.38%
20,533 $2.93 Million
Q1 2024

May 13, 2024

BUY
$102.11 - $135.92 $431,312 - $574,126
4,224 Added 25.45%
20,820 $2.67 Million
Q4 2023

Feb 09, 2024

BUY
$87.78 - $105.45 $606,910 - $729,081
6,914 Added 71.41%
16,596 $1.72 Million
Q3 2023

Nov 02, 2023

BUY
$90.94 - $199.54 $437,967 - $960,984
4,816 Added 98.97%
9,682 $880,000
Q2 2023

Aug 03, 2023

SELL
$155.98 - $172.65 $46,482 - $51,449
-298 Reduced 5.77%
4,866 $787,000
Q1 2023

May 15, 2023

BUY
$132.34 - $159.14 $39,569 - $47,582
299 Added 6.15%
5,164 $821,000
Q4 2022

Jan 10, 2023

SELL
$102.55 - $135.33 $60,299 - $79,574
-588 Reduced 10.78%
4,865 $0
Q2 2022

Aug 08, 2022

BUY
$103.24 - $121.81 $562,967 - $664,229
5,453 New
5,453 $607,000
Q1 2022

May 11, 2022

SELL
$93.1 - $112.54 $389,809 - $471,204
-4,187 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$95.88 - $117.08 $401,449 - $490,213
4,187 New
4,187 $469,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $200B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Coldstream Capital Management Inc Portfolio

Follow Coldstream Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coldstream Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Coldstream Capital Management Inc with notifications on news.